Most mammalian mRNAs are conserved targets of microRNAs.
By Robin C. Friedman, Kyle Kai-How Farh, C. Burge, David P. Bartel. Genome Research, 2008
8,637 citations recorded by the source corpus.
MicroRNAs (miRNAs) are small endogenous RNAs that pair to sites in mRNAs to direct post-transcriptional repression. Many sites that match the miRNA seed (nucleotides 2-7), particularly those in 3' untranslated regions (3'UTRs), are preferentially conserved. Here, we overhauled our tool for finding preferential conservation of sequence motifs and applied it to the analysis of human 3'UTRs, increasing by nearly threefold the detected number of preferentially conserved miRNA target sites. The new tool more efficiently incorporates new genomes and more completely controls for background conservation by accounting for mutational biases, dinucleotide conservation rates, and the conservation rates of individual UTRs. The improved background model enabled preferential conservation of a new site type, the "offset 6mer," to be detected. In total, >45,000 miRNA target sites within human 3'UTRs are conserved above background levels, and >60% of human protein-coding genes have been under selective pressure to maintain pairing to miRNAs. Mammalian-specific miRNAs have far fewer conserved targets than do the more broadly conserved miRNAs, even when considering only more recently emerged targets. Although pairing to the 3' end of miRNAs can compensate for seed mismatches, this class of sites constitutes less than 2% of all preferentially conserved sites detected. The new tool enables statistically powerful analysis of individual miRNA target sites, with the probability of preferentially conserved targeting (P(CT)) correlating with experimental measurements of repression. Our expanded set of target predictions (including conserved 3'-compensatory sites), are available at the TargetScan website, which displays the P(CT) for each site and each predicted target.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/2a2e5cfffe3c6b569e3b3311b699b482e96fe0c6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- David P. Bartel
- Scott M. Hammond
- Phillip A. Sharp
- Carlo Maria Croce
- Danish H Sayed
- M. Abdellatif
- Thomas Tuschl
- Nikolaus Rajewsky
In Molecular Biology
- David P. Bartel
- Scott M. Hammond
- Phillip A. Sharp
- Thomas Tuschl
- Carlo Maria Croce
- Phillip D. Zamore
- Eugene Berezikov
- M. Abdellatif
Citations in the corpus
- MicroRNAs in human cancer. (2013, background): “miRNAs regulate a large number of genes, some estimates reporting miRNA regulation of up to 60% of the human genome, making it challenging to attribute a phenotype after mis-expression of a particular miRNA through its action on only a subset of targets [ 111, 180 ] .”
- miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis (2020, background): “Previous studies have shown that miRNA encoding sequences form up to 1% of the human genome [10].”
- Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs (2011, neutral): “…of Turin, Turin, Italy 5Computational Medicine Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA 6Present address: Department of Dermatology, New York University School of Medicine, 522 First Avenue, Smilow 406, New York, NY 10016, USA *Correspondence:…”
- Tools for Sequence-Based miRNA Target Prediction: What to Choose? (2016, methodology): “Conversely, when the same context++ score is obtained for multiple miRNA:mRNA interactions, the PCT score should be taken into consideration for the purposes of prioritization.”
- Posttranscriptional regulation of microRNA biogenesis in animals. (2010, background): “…either of the RNA helicases p68 or p72, cofactors of the Microprocessor complex, results in a reduction in the levels of a particular set of miRNAs (Fukuda et al., 2007), suggesting a role for p68 and p72 in promoting Drosha cleavage of a subset of miRNAs. p68 and p72 interact with a large number…”
- The Emerging Paradigm of Network Medicine in the Study of Human Disease (2012, background): “29–31 It is estimated that most messenger RNA transcripts are regulated by miRNA, 32,33 with each miRNA ( (cid:2) 700 identified mammalian miRNA) typically repressing expression of multiple mRNA (at times, (cid:2) 100 targets simultaneously).”
- miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions (2013, methodology): “Many databases such as microRNA.org (10), miRGen (11), miRGator (12), miRDB (13) and miRNAMap (14) identify miRNA target interactions (MTIs) using a number of target prediction tools like TargetScan (15,16), miRanda (17), PicTar (18), RNAhybrid (19) and PITA (20).”
- miRBase: integrating microRNA annotation and deep-sequencing data (2010, methodology): “In its place, we will develop an aggregation service that integrates microRNA target predictions from all the popular target prediction sites [for example, TargetScan (19), PicTar (20), microCosm, DIANA-microT (21), microrna.”
- MicroRNA Functions in Stress Responses (2010, neutral): “A.K.L.L. was a special fellow of the Leukemia and Lymphoma Society.”
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions (2011, background): “The influence of miRNAs on gene expression is predicted to be widespread, with more than 60% of human protein coding genes being subject to regulation by miRNAs.(5) Among the p53-regulated miR NAs, miR‐34a seems to display the most pronounced induction by p53.”
- ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs (2014, methodology): “In recent years, comparative genomic methods have been developed that allow relatively accurate computational prediction of regulatory sites for hundreds of TFs and miRNAs on a genome-wide scale (van Nimwegen 2007; Friedman et al. 2009; Arnold et al. 2012a).”
- microRNAs in cancer (2013, background): “In addition, miRNA profiles can subgroup acute lymphoblastic leukemia (ALL) specimens into three major groups: one containing all t(9;22) BCR/ABL-positive and t(12;21) TEL/AML1-positive samples, a second containing T cell ALL samples, and a third containing the MLL gene rearrangement (35).”